Showing results (171-180 of 303) with videos related to
Sort By:
Pageof 31
Journal of Clinical Immunology|May 10, 2002
Treatment of leukemia by alloreactive lymphocytes and nonmyeloablative stem cell transplantationShimon Slavin, Arnon Nagler, Michael Y Shapira, et al.Reviews in Clinical and Experimental Hematology|August 7, 2001
Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disordersS Slavin, A Nagler, M Aker, et al.Seminars in Oncology|February 19, 2004
Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy--from bench to patient bedsideShimon Slavin, Shoshana Morecki, Lola Weiss, et al.Annals of Hematology|July 27, 2007
The oxidative status of blood cells in a murine model of graft-versus-host diseaseJohnny Amer, Lola Weiss, Shoshana Reich, et al.Journal of Neurosurgical Anesthesiology|January 15, 2000
Inhibition of cyclooxygenase 2 by nimesulide decreases prostaglandin E2 formation but does not alter brain edema or clinical recovery after closed head injury in ratsL Koyfman, J Kaplanski, A A Artru, et al.Burns : Journal of the International Society for Burn Injuries|February 1, 1995
Oro-maxillofacial skeletal deformities resulting from burn scar contractures of the face and neckO Nahlieli, J P Kelly, A M Baruchin, et al.Leukemia Research|August 31, 2007
Induction of late graft-versus-host disease in a patient post-allogeneic stem cell transplantation by progesterone in conjunction with donor lymphocyte infusionBenjamin Gesundheit, Michael Y Shapira, Alexander Maly, et al.Experimental Neurology|August 1, 1992
Changes in brain polyamine levels following head injuryE Shohami, J L Nates, L Glantz, et al.Clinical Transplants|September 25, 2004
Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disordersShimon Slavin, Mehmet Aker, Michael Y Shapira, et al.Brain & Development|January 1, 1990
Muscle involvement in mucolipidosis IVR Weitz, I Kramer, I Nissenkorn, et al.Pageof 31